205 related articles for article (PubMed ID: 1192353)
1. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE
Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353
[TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G
Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
[TBL] [Abstract][Full Text] [Related]
3. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
Van Scott EJ; Kalmanson JD
Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
[No Abstract] [Full Text] [Related]
4. Topical nitrogen mustard in mycosis fungoides.
Zachariae H
Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
[TBL] [Abstract][Full Text] [Related]
5. Topical chemotherapy of mycosis fungoides.
Grekin DA; Zackheim HS; Epstein EH
Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
[TBL] [Abstract][Full Text] [Related]
6. Complete regressions of mycosis fungoides with topical mechlorethamine hydrochloride.
Van Scott EJ
JAMA; 1972 Nov; 222(9):1172. PubMed ID: 4678061
[No Abstract] [Full Text] [Related]
7. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
du Vivier A; Vollum DI
Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
[TBL] [Abstract][Full Text] [Related]
8. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
9. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
Arundell FD; Chan WH
Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
[TBL] [Abstract][Full Text] [Related]
10. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
Monk BE; Vollum DI; du Vivier AW
Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
[No Abstract] [Full Text] [Related]
11. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
Zachariae H; Thestrup-Pedersen K; Søgaard H
Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
[TBL] [Abstract][Full Text] [Related]
12. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
13. Topical mechlorethamine therapy for early stage mycosis fungoides.
Ramsay DL; Halperin PS; Zeleniuch-Jacquotte A
J Am Acad Dermatol; 1988 Oct; 19(4):684-91. PubMed ID: 3183094
[TBL] [Abstract][Full Text] [Related]
14. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
15. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides, nitrogen mustard and skin cancer.
Du Vivier A; Vonderheid EC; Van Scott EJ; Urbach F
Br J Dermatol; 1978 Jul; 99(1):61-3. PubMed ID: 678466
[TBL] [Abstract][Full Text] [Related]
17. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
Ramsay DL; Parnes RE; Dubin N
Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
19. Commentary and update: topical chemotherapy with mechlorethamine for mycosis fungoides.
Vonderheid EC; Van Scott EJ
Cleve Clin Q; 1983; 50(2):97-100. PubMed ID: 6640944
[No Abstract] [Full Text] [Related]
20. Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.
Waldorf DS; Haynes HA; Van Scott EJ
Ann Intern Med; 1967 Aug; 67(2):282-90. PubMed ID: 6036390
[No Abstract] [Full Text] [Related]
[Next] [New Search]